Literature DB >> 8179392

Aspergillosis of the posterior mediastinum.

W J Wells1, A H Fox, P R Theodore, L A Ross, P Stanley, V A Starnes.   

Abstract

Invasive pulmonary Aspergillus, although rare in the general population, represents an important cause of morbidity and mortality among immunosuppressed patients. However, mediastinal invasion by Aspergillus is very uncommon, with few cases documented in the literature. Among 13 immunosuppressed pediatric patients recently diagnosed with invasive pulmonary aspergillosis, 3 have had posterior mediastinal invasion with severe complications. Rupture of a mycotic aortic aneurysm occurred in 2 patients, one of whom was operated on successfully. The infection involved the spinal cord with severe neurologic sequelae in 2 patients. We report our experience to make our colleagues aware of this problematic disease, which may be more prevalent in the current population of highly immunosuppressed pediatric patients.

Entities:  

Mesh:

Year:  1994        PMID: 8179392     DOI: 10.1016/0003-4975(94)91365-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Mycotic aneurysm of the distal aortic arch caused by Aspergillus.

Authors:  Mitsuharu Hosono; Koji Hattori; Toshihiko Shibata; Yasuyuki Sasaki; Hidekazu Hirai; Shigefumi Suehiro
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-04

2.  Surgical treatment of mediastinal aspergilloma in a immunocompetent patient.

Authors:  Jae Hong Lim; Ji Seong Kim; Chan Kyu Yang; Chang Hyun Kang; Young Tae Kim; In Kyu Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-08-05

3.  Giant intrathoracic mycotic aneurysm of left subclavian artery.

Authors:  R P Bansal; Prerna Gupta; Lalit M Sharma
Journal:  Indian J Med Paediatr Oncol       Date:  2010-07

4.  A post-COVID-19 Aspergillus fumigatus posterior mediastinitis: Case report.

Authors:  Nadine El Hoyek; Jacques Ghorayeb; Iskandar Daou; Dany Jamal; Nathalie Mahfoud; Georges Nawfal
Journal:  SAGE Open Med Case Rep       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.